降脂药物的合理应用与药物性肝损伤

doi:10.3969/j.issn.1672-5069.2017.02.004

Abstract

Zheng Kai，Li Hai.. Hepatotoxicity of lipid-lowering agents[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 139-141.

[1] Bjornsson ES. Hepatotoxicity of statins and other lipid-lowering agents. Liver Int，2016[ahead of print].
[2] 范建高，颜士岩. 代谢综合征与脂肪肝. 临床肝胆病杂志，2016，32（3）:407-410.
[3] 范建高，潘勤. 加强高脂血症脂肪肝的基础和临床研究. 实用肝脏病杂志，2011，14（4）:241-242.
[4] Desai CS，Martin SS，Blumenthal RS. Non-cardiovascular effects associated with statins. BMJ，2014，349:g3743.
[5] 傅青春. 药物性肝损伤诊断的因果评分系统. 实用肝脏病杂志，2014，17（6）:569-571.
[6] Demyen M，Alkhalloufi K，Pyrsopoulos NT. Lipid-lowering agents and hepatotoxicity. Clin Liver Dis，2013，17（4）:699-714.
[7] Tolosa L，Carmona A，Castell JV，et al. High-content screening of drug-induced mitochondrial impairment in hepatic cells:effects of statins. Arch Toxicol，2015，89（10）:1847-1860.
[8] Abdoli N，Heidari R，Azarmi Y，et al. Mechanisms of the statins cytotoxicity in freshly isolated rat hepatocytes. J Biochem Mol Toxicol，2013，27（6）:287-294.
[9] Szabo M，Veres Z，Batai-Konczos A，et al. Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes. Toxicol In Vitro，2014，28（6）:1136-1143.
[10] Chang CH，Chang YC，Lee YC，et al. Severe hepatic injury associated with different statins in patients with chronic liver disease:a nationwide population-based cohort study. J Gastroenterol Hepatol，2015，30（1）:155-162.
[11] Perdices EV，Medina-Caliz I，Hernando S，et al. Hepatotoxicity associated with statin use:analysis of the cases included in the Spanish Hepatotoxicity Registry. Rev Esp Enferm Dig，2014，106（4）:246-254.
[12] Habib S，Shaikh OS. Drug-induced acute liver failure. Clin Liver Dis，2017，21（1）:151-162.
[13] Kubatka P，Kruzliak P，Rotrekl V，et al. Statins in oncological research:from experimental studies to clinical practice. Crit Rev Oncol Hematol，2014，92（3）:296-311.
[14] 范建高，蔡晓波. 他汀类药物肝脏安全性问题. 中华心血管病杂志，2007，21（6）:589-592.
[15] Younoszai Z，Li Z，Stepanova M，et al. Statin use is not associated with liver related mortality. Ann Hepatol，2013，13（1）:84-90.
[16] Lewis JH，Mortensen ME，Zweig S，et al. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective，randomized，double-blind，placebo-controlled，multicenter trial. Hepatology，2007，46（5）:1453-1463.
[17] Onofrei MD，Butler KL，Fuke DC，et al. Safety of statin therapy in patients with preexisting liver disease. Pharmacotherapy，2008，28（4）:522-529.
[18] Abraldes JG，Albillos A，Banares R，et al. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension:a randomized controlled trial. Gastroenterology，2009，136（5）:1651-1658.
[19] Pollo-Flores P，Soldan M，Santos UC，et al. Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis:A randomized controlled trial. Dig Liver Dis，2015，47（11）:957-963.
[20] 范建高，李光明. 他汀类药物在慢性肝病中的应用. 传染病信息，2011，22（5）:261-266.
[21] Chatrath H，Vuppalanchi R，Chalasani N. Dyslipidemia in patients with nonalcoholic fatty liver disease. Semin Liver Dis，2012，32（1）:22-29.
[22] Sarges P，Steinberg JM，Lewis JH. Drug-Induced Liver Injury: Highlights from a review of the 2015 literature. Drug Saf，2016，39（9）:801-821.
[23] 钟碧慧. 降脂药物在NAFLD患者中的合理应用. 实用肝脏病杂志，2016，19（2）:143-146.
[24] Russo MW，Hoofnagle JH，Gu J，et al. Spectrum of statin hepatotoxicity:experience of the drug-induced liver injury network. Hepatology，2014，60（2）:679-686.

Hepatotoxicity of lipid-lowering agents

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liu Liwei, Zhao Xinyan. Clinicopathological features of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 160-163.
[2]	Huang Chunyang, Shan Jing, Liao Huiyu, Huang Yunli, Han Ying, Zhang Xiaodan, Du Xiaofei, Ren Meixin, Bian Xinqu, Liu Yanmin. Clinical and laboratory characteristics of patients with drug-induced liver injury receiving glucocorticoid therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 208-211.
[3]	Wu Xiuxin, Zhang Huiyong, Zhang Kai. Changes of plasma microRNA-4284 in patients with anti-tuberculosis drug-induced hepatotoxicity [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 212-215.
[4]	Sun Wenjing, Chen Dongfeng.. Literature analysis about RUCAM scale and Maria scale in diagnosis of Chinese patients with drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 881-884.
[5]	Tong Xin, Fan Hua. Efficacy of bicyclic alcohol on liver function in gastric cancer patients with chemotherapy-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 625-626.
[6]	Liu Cong, Wang Tingting, Zuo Lili, et al. Analysis of patients with drug-induced liver injury in recent 3 years [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 639-640.
[7]	Liu Liangyi, Su Dongyuan. Comparison of clinical and liver pathological features of patients with drug-induced liver injury and autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 463-464.
[8]	Wei Lujia, Li Qingxiang, Ji Qingwei.. Clinical features of amiodarone-induced acute liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 424-426.
[9]	Zhang Dai，Wang Bingyuan.. Novel medicines, new members of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 129-131.
[10]	Wang Yuxia，Du Jian.. Diagnostic and therapeutic progress in anti-thyroid drug -induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 135-138.
[11]	Zhou Xueshi，Yin Cuilan，Lu Zhonghua，et al.. Drug-induced liver injury：a report of two cases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 250-251.
[12]	Du Shuixian, Lu Linlin, Miao Yingxia, et al.. Features of children with drug-induced liver injury:An analysis of 34 cases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(5): 607-609.
[13]	Yao Yunjie, Xiao Lang, Yang Caixing, et al. Clinical and pathological features of patients with Chinese herbal drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(4): 441-444.
[14]	Li Zhiqun， Xue Runguo.. Drug-induced liver injury in elderly persons [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(6): 575-577.
[15]	Zhang Bin， Ding Shenhua， Qian Xuemei， et al.. Emodin-induced drug-induced liver injury in rats [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(6): 607-610.